Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6890.00    90.00 (1.32%)
Bid:
6895.00
Ask:
6900.00
Spread: 5.00 (0.073%)
Market Cap: £5.08b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Board Appointment

9 Mar 2021 08:30

RNS Number : 5188R
Spirax-Sarco Engineering PLC
09 March 2021
 

 

 

9th March 2021

 

Board Appointment

 

Spirax-Sarco Engineering plc, the world leader in thermal energy management, peristaltic pumping and associated fluid path technologies, announces the following Board appointment in accordance with its ongoing succession planning.

 

Richard Gillingwater will join the Board as an Independent Non‑Executive Director with immediate effect. Richard will assume the role of Senior Independent Director on 1st August 2021, succeeding Dr Trudy Schoolenberg who will step down from the Board after completing nine years as a Director.

 

Richard has held a range of executive positions within global investment banks including Kleinwort Benson, Credit Suisse and Barclays de Zoete Wedd. He is currently Chair at SSE plc (stepping down at the end of March), Chair of Janus Henderson Group plc, Senior Independent Director of Whitbread plc and Governor at The Wellcome Trust. Richard holds an MBA from the International Institute for Management Development, a BA Law from Oxford University and is a qualified solicitor.

 

Jamie Pike, Chair, commented, "I am delighted to welcome Richard to the Board of Directors. Richard's strong investment, financial and non-executive experience, combined with his many years working with international businesses, will greatly assist the development of the Group. As Senior Independent Director, Richard will also continue our close engagement with shareholders."

 

Richard's appointment is part of the succession planning undertaken by the Nomination Committee to recruit Non-Executive Directors with the skills and experience required to support the implementation of our strategy for growth.

 

There are no further disclosures to be made pursuant to Listing Rule 9.6.13.

 

Enquiries:

Andy Robson

Group General Counsel & Company Secretary

Tel: 01242 535035

 

About SpiraxSarco Engineering plc

SpiraxSarco Engineering plc is a thermal energy management and niche pumping specialist. It comprises three worldleading businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions businesses provide a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both businesses help their end users to improve production efficiency, meet their environmental sustainability targets, improve product quality and enhance the safety of their operations. WatsonMarlow provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham, UK, has strategically located manufacturing plants around the world and employs over 7,800 people, of whom close to 1,800 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good indices.

 

Further information can be found at www.spiraxsarcoengineering.com

 

RNS filter: Inside information prior to release

 

LEI 213800WFVZQMHOZP2W17

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALVLFBFXLLBBK
Date   Source Headline
22nd Apr 20253:52 pmRNSDirector/PDMR Shareholding
11th Apr 20255:04 pmRNSHolding(s) in Company
8th Apr 20259:34 amRNSDirector/PDMR Shareholding
8th Apr 20259:32 amRNSNotice of AGM
27th Mar 20254:06 pmRNSDirector/PDMR Shareholding
27th Mar 20254:06 pmRNSDirector/PDMR Shareholding
19th Mar 202511:43 amRNSHolding(s) in Company
12th Mar 20257:00 amRNSDividend Declaration
11th Mar 20257:00 amRNS2024 Full Year Results
10th Mar 20251:42 pmRNSDirector/PDMR Shareholding
10th Feb 20252:23 pmRNSDirector/PDMR Shareholding
31st Jan 20259:00 amRNSBoard Appointment
14th Jan 20253:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSBoard Chair Succession
11th Dec 20241:53 pmRNSDirector/PDMR Shareholding
27th Nov 20244:18 pmRNSDirector/PDMR Shareholding
15th Nov 20241:19 pmRNSDirector/PDMR Shareholding
14th Nov 20247:00 amRNSTrading Update
16th Oct 20248:48 amRNSHolding(s) in Company
11th Oct 20241:50 pmRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSDirector/PDMR Shareholding
10th Oct 20243:29 pmRNSHolding(s) in Company
3rd Oct 20247:00 amRNSCapital Markets Event
18th Sep 20249:47 amRNSHolding(s) in Company
16th Sep 202410:12 amRNSHolding(s) in Company
13th Sep 202410:57 amRNSHolding(s) in Company
12th Aug 202410:44 amRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNS2024 Half Year Results
1st Jul 20247:05 amRNSConfirmation of CFO Start Date
5th Jun 20243:46 pmRNSChange of Name
29th May 20248:45 amRNSBoard Succession
15th May 20244:56 pmRNSResult of AGM
15th May 20247:00 amRNSAGM Trading Statement
10th Apr 20244:44 pmRNSDirector/PDMR Shareholding
26th Mar 20249:33 amRNSDirector/PDMR Shareholding
20th Mar 202410:00 amRNSDirector/PDMR Shareholding
18th Mar 20242:34 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNS2023 Full Year Results
22nd Feb 20247:00 amRNSSpirax-Sarco Engineering rebrands as Spirax Group
1st Feb 20243:38 pmRNSChange of Director Details
30th Jan 202411:15 amRNSFuture Board Change
17th Jan 20247:00 amRNSLeadership Succession
18th Dec 20237:00 amRNSChief Financial Officer Appointment
21st Nov 20239:15 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSShare Purchases
20th Nov 20237:00 amRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSTrading Update
11th Oct 20238:40 amRNSDirector/PDMR Shareholding
25th Aug 20239:30 amRNSHolding(s) in Company
25th Aug 20238:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.